New Dose Strategy for Ceritinib May Improve Outcomes in ALK-Positive NSCLC READ ARTICLE
ESMO DOI: 10.1016/j.annonc.2020.10.386
Authors: Z. Qiu, K. Wang, M. Huang, M. Yu, C. Liu, X. Xian
New Dose Strategy for Ceritinib May Improve Outcomes in ALK-Positive NSCLC READ ARTICLE
ESMO DOI: 10.1016/j.annonc.2020.10.386
Authors: Z. Qiu, K. Wang, M. Huang, M. Yu, C. Liu, X. Xian